VNDA
Vanda Pharmaceuticals Inc
NASDAQ: VNDA · HEALTHCARE · BIOTECHNOLOGY
$7.10
+0.71% today
Updated 2026-04-30
Market cap
$411.32M
P/E ratio
—
P/S ratio
1.90x
EPS (TTM)
$-3.74
Dividend yield
—
52W range
$4 – $10
Volume
2.8M
WallStSmart proprietary scores
39
out of 100
Grade: D
Sell
Investment rating
3.3
Growth
D5.0
Quality
C+2.0
Profitability
F6.3
Valuation
B—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$15.50
+118.31%
12-Month target
—
—
Intrinsic (DCF)
$40.21
Margin of safety
+84.78%
0 Strong Buy4 Buy1 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ 84.78% below intrinsic value
Risks
- Thin margins at -102.00%
- Negative free cash flow $-29.52M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $254.38M | $192.64M | $198.77M | $216.10M | $216.10M |
| Net income | $6.28M | $2.51M | $-18.90M | $-220.47M | $-141.19M |
| EPS | — | — | — | — | $-3.74 |
| Free cash flow | $31.30M | $12.42M | $-16.25M | $-110.44M | $-29.52M |
| Profit margin | 2.47% | 1.30% | -9.51% | -102.02% | -102.00% |
Peer comparison
Smart narrative
Vanda Pharmaceuticals Inc trades at $7.10. Our Smart Value Score of 39/100 indicates the stock is weak. TTM revenue stands at $216.10M. with profit margins at -102.00%. Our DCF model estimates intrinsic value at $40.21.
Frequently asked questions
What is Vanda Pharmaceuticals Inc's stock price?
Vanda Pharmaceuticals Inc (VNDA) trades at $7.10.
Is Vanda Pharmaceuticals Inc overvalued?
Smart Value Score 39/100 (Grade D, Sell). DCF value $40.21.
What is the price target of Vanda Pharmaceuticals Inc (VNDA)?
The analyst target price is $15.50, representing +118.3% upside from the current price of $7.10.
What is the intrinsic value of Vanda Pharmaceuticals Inc (VNDA)?
Based on our DCF model, intrinsic value is $40.21, a +84.8% margin of safety versus $7.10.
What is Vanda Pharmaceuticals Inc's revenue?
TTM revenue is $216.10M.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio1.90x
ROE-50.90%
Beta0.71
50D MA$7.53
200D MA$6.07
Shares out0.06B
Float0.05B
Short ratio—
Avg volume2.8M
Performance
1 week+0.15%
1 month+2.86%
3 months-11.05%
YTD-22.45%
1 year—
3 years—
5 years—